SYNH Syneos Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SYNH

Price (delayed)

$34.665

Market cap

$3.58B

P/E Ratio

13.38

Dividend/share

N/A

EPS

$2.59

Enterprise value

$6.37B

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to ...

Highlights
The P/E is 82% below the 5-year quarterly average of 74.2 and 41% below the last 4 quarters average of 23.1
Syneos Health's debt has decreased by 6% YoY and by 4.9% QoQ
Syneos Health's EPS has increased by 15% YoY but it has decreased by 7% QoQ
The net income is up by 13% year-on-year but it is down by 7% since the previous quarter
Syneos Health's gross margin has decreased by 2.1% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.syneoshealth.com/
Peers: OVID

Key stats

What are the main financial stats of SYNH
Market
Shares outstanding
103.24M
Market cap
$3.58B
Enterprise value
$6.37B
Valuations
Price to earnings (P/E)
13.38
Price to book (P/B)
1.02
Price to sales (P/S)
0.66
EV/EBIT
16.04
EV/EBITDA
9.88
EV/Sales
1.18
Earnings
Revenue
$5.39B
EBIT
$396.96M
EBITDA
$644.14M
Free cash flow
$333.52M
Per share
EPS
$2.59
Free cash flow per share
$3.24
Book value per share
$33.96
Revenue per share
$52.37
TBVPS
$25.45
Balance sheet
Total assets
$8.2B
Total liabilities
$4.7B
Debt
$2.9B
Equity
$3.5B
Working capital
$219.25M
Liquidity
Debt to equity
0.83
Current ratio
1.13
Quick ratio
1.02
Net debt/EBITDA
4.33
Margins
EBITDA margin
11.9%
Gross margin
23.3%
Net margin
4.9%
Operating margin
7.5%
Efficiency
Return on assets
3.2%
Return on equity
7.9%
Return on invested capital
10.4%
Return on capital employed
6.1%
Return on sales
7.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SYNH stock price

How has the Syneos Health stock price performed over time
Intraday
-1.07%
1 week
2.62%
1 month
-6.91%
1 year
-58.3%
YTD
-5.49%
QTD
-5.49%

Financial performance

How have Syneos Health's revenue and profit performed over time
Revenue
$5.39B
Gross profit
$1.25B
Operating income
$403.19M
Net income
$266.5M
Gross margin
23.3%
Net margin
4.9%
The net income is up by 13% year-on-year but it is down by 7% since the previous quarter
Syneos Health's net margin has increased by 9% YoY but it has decreased by 8% QoQ
The company's operating income fell by 8% QoQ but it rose by 3.6% YoY
SYNH's operating margin is down by 7% since the previous quarter

Growth

What is Syneos Health's growth rate over time

Valuation

What is Syneos Health stock price valuation
P/E
13.38
P/B
1.02
P/S
0.66
EV/EBIT
16.04
EV/EBITDA
9.88
EV/Sales
1.18
The P/E is 82% below the 5-year quarterly average of 74.2 and 41% below the last 4 quarters average of 23.1
Syneos Health's EPS has increased by 15% YoY but it has decreased by 7% QoQ
SYNH's price to book (P/B) is 49% lower than its 5-year quarterly average of 2.0 and 43% lower than its last 4 quarters average of 1.8
Syneos Health's equity has increased by 4.2% from the previous quarter and by 2.4% YoY
The price to sales (P/S) is 48% lower than the 5-year quarterly average of 1.3 and 39% lower than the last 4 quarters average of 1.1
SYNH's revenue is up by 3.5% YoY

Efficiency

How efficient is Syneos Health business performance
SYNH's ROIC is down by 14% from the previous quarter
Syneos Health's return on sales has decreased by 14% QoQ and by 2.6% YoY
Syneos Health's return on equity has increased by 11% YoY but it has decreased by 8% QoQ
Syneos Health's return on assets has increased by 10% YoY but it has decreased by 9% QoQ

Dividends

What is SYNH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SYNH.

Financial health

How did Syneos Health financials performed over time
The total assets is 74% higher than the total liabilities
The company's current ratio rose by 6% YoY
Syneos Health's quick ratio has increased by 3% YoY but it has decreased by 2.9% QoQ
Syneos Health's debt is 17% lower than its equity
SYNH's debt to equity is down by 9% since the previous quarter and by 8% year-on-year
Syneos Health's debt has decreased by 6% YoY and by 4.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.